Ionis Pharmaceuticals, Inc. (IONS) Management Presents at Stifel 2019 Healthcare Conference (Transcript)Seeking Alpha • 11/19/19
Ionis Pharmaceuticals, Inc. (IONS) CEO Stanley Crooke on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/07/19
Here's One Drugmaker That Popped On Earnings — And Two That Didn'tInvestors Business Daily • 11/06/19
Ionis Pharmaceuticals (IONS) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/06/19
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/30/19
Ionis Pharmaceuticals: Platform Technology Play With Multiple Irons In The FireSeeking Alpha • 08/30/19
Akcea and Ionis to Present New Data for TEGSEDI and AKCEA-TTR-LRx at Two Upcoming Medical MeetingsGlobeNewsWire • 08/29/19
Ionis Pharmaceuticals Inc (IONS) Chairman and CEO Stanley T Crooke Sold $1.6 million of SharesGuruFocus • 08/22/19
Ionis Pharmaceuticals, Inc. (IONS) CEO Stanley Crooke on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19
Ionis Pharmaceuticals Inc (IONS) Chairman & CEO Stanley T Crooke Sold $702,500 of SharesGuruFocus • 07/22/19
Ionis Pharmaceuticals, Inc. (IONS) CEO Stanley Crooke on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19
This Highly-Rated Biotech Stock Just Topped First-Quarter EstimatesInvestors Business Daily • 05/09/19
Ionis Pharmaceuticals (IONS) Beats Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/09/19